SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SIBIA Neurosciences (SIBI) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (246)11/5/1998 11:14:00 AM
From: Mike McFarland  Respond to of 579
 
Can't argue with that...still, would have
liked to have halved my holdings above $6.
With only something like 23,000 shares changing
hands so far today, sibi is certainly not
tradable...and I never considered it to be.
Remember, I'm one of the guys sitting on a
pile of ntii--so liquidity is certainly not
paramount in my mind. Ooof, sombody just gave
up shares at 4 1/4, ouch.

I suppose it is the willingness to buy shares
at distressed prices which gives an advantage to
individual investors. Today's WSJ shows a table
of small cap fund performance, best fund up some-
thing like 50% for the year. Heh, big deal!

--MM



To: scaram(o)uche who wrote (246)12/18/1998 4:18:00 PM
From: Czechsinthemail  Read Replies (2) | Respond to of 579
 
Rick,

However, the "basket" approach worked very effectively for me 12/94, and good third-tier science is a bigger bargain now.

SIBI seems to be dropping some, perhaps on year end tax-loss selling. I've been considering adding some additional SIBI shares, but I'm wondering which among the other small biotechs do you see as the best values at this point for filling your basket.

Baird


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News